Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive Disorder.

Overview of attention for article published in The Primary Care Companion to CNS Disorders, February 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs: 1 blog

twitter: 7 X users

Readers on

mendeley: 20 Mendeley

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 50,329 followers.

RT @rogersmcintyre: Interesting to see this improvement in cognitive functioning in depression with S methadone. Hope it’s replicated in la…

Interesting to see this improvement in cognitive functioning in depression with S methadone. Hope it’s replicated in large RCT with cognition is primary. https://t.co/8Xn72JBNUD

RT @AnxietyNews: Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With M…

Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive Disorder https://t.co/CTnQS0CkBd

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.